uftoral has been researched along with Carcinoma, Epidermoid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasebe, K; Sasaki, S; Takamura, H; Urade, M; Yagi, M | 1 |
| Azegami, T; Fujimori, S; Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Ohtsuka, A; Tanaka, K | 1 |
| Ikeda, H; Inokuchi, T; Irie, A; Mizoguchi, Y; Shibahara, K; Takebe, Y; Yamada, K | 1 |
| Ikemura, K; Oya, R | 1 |
| Beauchamp, RD; Berlin, J; Blanke, CD; Caillouette, C; Chakravarthy, B; Choy, H; Leach, S; Roberts, J; Shyr, Y; Tarpley, J; Tedesco, KL; Teng, M; Wyman, K | 1 |
| Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Miyazawa, H; Uehara, S | 1 |
| Amano, T; Hayashi, Y; Imada, T; Kubo, A; Maehara, T; Matsumoto, A; Morohoshi, T | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y | 1 |
| Chida, E; Fujii, M; Fukuda, S; Furuta, Y; Inuyama, Y; Kanzaki, J; Nagahashi, T; Shirato, H; Yagi, K | 1 |
| Colevas, AD | 1 |
| Diaz-Rubio, E; Garcia Carbonero, I; González-Larriba, JL; Perez Segura, P; Sastre Valera, J | 1 |
| Kimura, S; Naito, Y; Nakajima, T; Ohtake, K; Saku, T; Yoshizawa, M | 1 |
| Hashimoto, Y; Iwasaki, K; Oida, I; Ozawa, T; Usami, A; Yamada, M | 1 |
| Kasai, N; Mutoh, Y | 1 |
| Ashida, H; Iida, S; Kimura, J; Matsumoto, T; Tanaka, A; Teramura, C | 1 |
| Haga, S; Hirai, M; Kajiwara, T; Naritaka, Y; Ogawa, K; Otani, Y | 1 |
| Fujisawa, A; Ikeda, H; Inokuchi, T; Kitamura, A; Nonaka, M; Ohba, S; Tobita, T; Uehara, M | 1 |
2 review(s) available for uftoral and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The role of chemotherapy in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maxillary Sinus Neoplasms; Peplomycin; Survival Rate; Tegafur; Uracil | 1997 |
Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Head and Neck Neoplasms; Humans; Neoplasm Staging; Tegafur; Uracil | 1997 |
3 trial(s) available for uftoral and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Radiation-Sensitizing Agents; Tegafur; Uracil | 2005 |
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1996 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Combinations; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
12 other study(ies) available for uftoral and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tegafur; Uracil | 2003 |
[A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pyridines; Remission Induction; Tegafur; Tongue Neoplasms; Uracil | 2003 |
Spontaneous regression of recurrent squamous cell carcinoma of the tongue.
Topics: Aged; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Tegafur; Tongue Neoplasms; Uracil | 2004 |
Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2006 |
[A case report of concomitant UFT-E and CDDP against lung epidermoid carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Combinations; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cricetinae; Drug Combinations; Lymphatic Metastasis; Male; Mouth Neoplasms; Neoplasm Transplantation; Tegafur; Uracil | 1998 |
[A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Combinations; Humans; Infusions, Intravenous; Laryngeal Neoplasms; Male; Tegafur; Uracil | 1999 |
[A case of carcinoma of lower lip showing excellent response to chemotherapy with UFT].
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Humans; Lip; Lip Neoplasms; Tegafur; Uracil | 1999 |
[A case in which palatal squamous cell carcinoma responded to UFT therapy].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Female; Humans; Palatal Neoplasms; Remission Induction; Tegafur; Uracil | 1999 |
[A case of esophageal cancer with excellent response to oral UFT treatment].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Esophagoscopy; Humans; Male; Tegafur; Uracil | 1999 |
[A case of squamous cell carcinoma of the oral floor showing a complete response to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Mouth Neoplasms; Remission Induction; Tegafur; Uracil | 2001 |